LABCORP HOLDINGS INC. vs RadNet, Inc., two Medical Diagnostics stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where LH and RDNT diverge most: on net margin, LH reads 7.0% and RDNT reads -0.9%; on return on equity, LH reads 11.7% and RDNT reads -1.5%. The rest of the comparable metrics sit closer together. What LH's price implies is a bet that sits within the historical range (whole-company basis). What RDNT's price implies is a somewhat stretched bet versus history (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | LH | RDNT |
|---|---|---|
| Price | $311.64 | $75.49 |
| Market cap | $25.6B | $5.9B |
| Sector | Medical Diagnostics | Medical Diagnostics |
| Stage | Mature | Growth |
| Implied growth (priced in) | +4.6% | — |
| P/E | 25.8 | — |
| P/B | 2.97 | 4.26 |
| P/S | 1.78 | 2.62 |
| EV/EBITDA | 18.7 | 27.2 |
| Revenue growth | +6.4% | +18.8% |
| Gross margin | 29.8% | — |
| Operating margin | 12.1% | 6.3% |
| Net margin | 7.0% | -0.9% |
| Return on equity | 11.7% | -1.5% |
| Return on assets | 5.4% | -0.5% |
| Return on invested capital | 8.2% | 1.9% |
| FCF yield | 4.5% | 5.2% |
| Dividend yield | 0.9% | — |
| Debt / equity | 0.68 | 0.98 |
| Current ratio | 1.80 | 1.48 |
| Altman Z (solvency) | 3.17 | 1.88 |
| Piotroski F (quality) | 7 / 9 | 5 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.